Rilutek is a brand name for the medication riluzole, which is an oral prescription medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of amyotrophic lateral sclerosis (ALS). ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and spinal cord, leading to muscle weakness and eventual paralysis.
Rilutek belongs to a class of drugs called glutamate modulators. It works by reducing the release of glutamate, a neurotransmitter that is believed to play a role in the progression of ALS. Glutamate can become excessively released in ALS patients, leading to excitotoxicity, a process in which excessive stimulation of nerve cells causes damage and cell death.
The exact mechanism of how Rilutek works in slowing the progression of ALS is not fully understood, but studies have shown that it may help prolong the overall survival and delay the need for tracheostomy in patients with ALS.
Rilutek is typically taken orally, usually twice a day, with or without food. It is important to follow the dosing instructions provided by the healthcare professional, as well as any additional advice or precautions for taking the medication.
As with any medication, Rilutek can cause side effects, which may include dizziness, fatigue, nausea, diarrhea, abdominal pain, and increased liver enzyme levels. It is important for patients to discuss any potential risks and benefits with their healthcare provider before starting Rilutek therapy.
